CRYOPORT, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CRYOPORT, INC. (CYRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 132.15 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 56.45K shares, a 125.22% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 84.34K shares, a 144.99% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 134.83K shares, a 258.22% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 25.07K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2026-06-30 | 132.15K shares 10-Q · filed 2026-08-06 | ||
| 2025-09-30 | 56.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 140.79K shares derived: sum of 2 quarters · filed 2025-11-06 | 275.62K shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 84.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 219.17K shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 134.83K shares 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | 25.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 59.49K shares derived: sum of 2 quarters · filed 2024-11-07 | 97.13K shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 34.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 72.06K shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 37.64K shares 10-Q · filed 2024-05-08 | ||
| 2023-09-30 | 61.06K shares 10-Q · filed 2023-11-09 | ||
| 2013-12-31 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | 70.00K shares derived: sum of 2 quarters · filed 2014-02-13 | 70.00K shares 10-Q · filed 2014-02-13 |
| 2013-09-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | 50.00K shares 10-Q · filed 2013-11-18 | |
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-14 | ||
| 2012-12-31 | 31.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | 68.75K shares derived: sum of 2 quarters · filed 2013-02-14 | 313.13K shares 10-Q · filed 2013-02-14 |
| 2012-09-30 | 36.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | 281.25K shares 10-Q · filed 2012-11-09 | |
| 2012-06-30 | 244.38K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |